Provectus Biopharmaceuticals Inc (PVCT) financials · rev $336.1K
Provectus Biopharmaceuticals Inc (PVCT) rev $336.1K.
| Line | FY2025 | FY2024 |
|---|---|---|
| Revenue | $336.1K | $617.1K |
| Cost of Revenue | $0 | $0 |
| Gross Profit | $0 | $0 |
| Operating Income | -$5.3M | -$4.5M |
| Net Income | -$5.4M | -$4.7M |
| EPS (Diluted) | $-0.01 | $-0.01 |
| Line | FY2025 | FY2024 |
|---|---|---|
| Total Assets | $697.5K | $1.0M |
| Current Assets | $567.9K | $976.8K |
| Cash & Equivalents | $251.3K | $307.4K |
| Inventory | $0 | $0 |
| PP&E | $3.0K | $4.9K |
| Total Liabilities | $7.0M | $7.0M |
| Current Liabilities | $6.9M | $7.0M |
| Short-term Debt | $0 | $0 |
| Long-term Debt | $0 | $0 |
| Total Debt | $0 | $0 |
| Shareholders' Equity | -$6.3M | -$6.0M |
| Retained Earnings | -$262.9M | -$257.4M |
| Line | FY2025 | FY2024 |
|---|---|---|
| Operating Cash Flow | -$3.3M | -$3.3M |
| CapEx | $0 | $0 |
| Investing Cash Flow | $0 | $0 |
| Financing Cash Flow | $3.1M | $2.7M |
| Dividends Paid | $0 | $0 |
| Net Change in Cash | -$238.4K | $0 |
| Free Cash Flow | $0 | $0 |
FAQ
What is PVCT P/E and revenue?
Provectus Biopharmaceuticals Inc (PVCT) rev $336.1K.
What is PVCT revenue?
Provectus Biopharmaceuticals Inc last cached revenue is $336.1K (FY2025).
Is PVCT profitable?
Provectus Biopharmaceuticals Inc last cached net income is -$5.4M.
What are PVCT total assets?
Provectus Biopharmaceuticals Inc last cached total assets are $697.5K.
What is PVCT free cash flow?
Provectus Biopharmaceuticals Inc last cached free cash flow is $0.
Not investment advice. Cached statements, not a live tape.